Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.68 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.64 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.64 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.64 |
| ▸ | PRKCA | P17252 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.60 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.60 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.60 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.60 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.60 |
| ▸ | CES2 | O00748 | 1/20 | 0.60 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.60 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9616638 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL8989675 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL8989730 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL7639177 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL8956657 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL9933462 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL10784010 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL10784004 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL3849574 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA | |
| SCHEMBL8989724 | 1.00 | DGKA (0.68) | DGKAPRKCEPRKCQPRKCDPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109370741-B | Switch lubricating oil composition and preparation method thereof | 兰州工业研究院 | 2021-08-10 | — | — | CN | claimed |
| US-20260109721-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | ALDEXCHEM KFT (HU) | 2026-04-23 | — | — | US | disclosed |
| EP-4646422-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | AldexChem Kft. (HU) | 2025-11-12 | — | — | EP | disclosed |
| WO-2025052296-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | ALDEXCHEM KFT. (HU) | 2025-03-13 | — | — | WO | disclosed |
| EP-4520765-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | AldexChem Kft. (HU) | 2025-03-12 | — | — | EP | disclosed |
| EP-3913039-B1 | BLEND OF ESTER COMPOUNDS | KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) | 2024-01-31 | — | — | EP | disclosed |
| US-11795134-B2 | Ester compounds, method for the production thereof and use thereof | KLÜBER LUBRICATION MÜNCHEN SE & CO. KG (DE) | 2023-10-24 | — | — | US | disclosed |
| EP-3609988-B1 | USE OF ESTER COMPOSITION | KLUEBER LUBRICATION MUENCHEN SE & CO KG (DE) | 2023-06-07 | — | — | EP | disclosed |
| CN-110431218-B | Novel ester compound, process for producing the same, and use thereof | 慕尼黑克吕伯尔润滑器股份两合公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-109370741-B | Switch lubricating oil composition and preparation method thereof | 兰州工业研究院 | 2021-08-10 | — | — | CN | disclosed |
| EP-2550954-B1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | NISSHIN OILLIO GROUP LTD (JP) | 2020-03-04 | — | — | EP | disclosed |
| EP-3609988-A1 | NOVEL ESTER COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF | Klüber Lubrication München SE & Co. KG (DE) | 2020-02-19 | — | — | EP | disclosed |
| EP-2494952-B1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | NISSHIN OILLIO GROUP LTD (JP) | 2018-02-28 | — | — | EP | disclosed |
| US-9028848-B2 | Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-9028850-B2 | Composition for cosmetics, cosmetic, method for producing oil-in-water emulsion cosmetic, and two separate layer-type cosmetic | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| US-20130303634-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | NISSHIN OILLIO GROUP LTD (JP) | 2013-11-14 | — | — | US | disclosed |
| EP-2550954-A1 | VASELINE-LIKE COMPOSITION, AND COSMETIC PREPARATION | The Nisshin Oillio Group, Ltd. (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20130005808-A1 | VASELINE-LIKE COMPOSITION AND COSMETIC | The Nisshin OilliO Group ,Ltd. (JP) | 2013-01-03 | — | — | US | disclosed |
| EP-2494952-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | The Nisshin Oillio Group, Ltd. (JP) | 2012-09-05 | — | — | EP | disclosed |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | THE NISSHIN OILLIO GROUP, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795134-B2 | Ester compounds, method for the production thereof and use thereof | CYP46A1, CYP17A1, CYP51A1 | DGKA 1164/4885PRKCE 2713/4885PRKCQ 2821/4885 |
| US-20120156271-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKG, MGLL | DGKA 5/4885PRKCE 402/4885PRKCQ 543/4885 |
| US-20260109721-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | SGMS1, SGMS2, AGO2 | DGKA 1550/4885PRKCE 4044/4885PRKCQ 4001/4885 |
| US-20130303634-A1 | COMPOSITION FOR COSMETICS, COSMETIC, METHOD FOR PRODUCING OIL-IN-WATER EMULSION COSMETIC, AND TWO SEPARATE LAYER-TYPE COSMETIC | GK, DGKA, DGKG | DGKA 2/4885PRKCE 398/4885PRKCQ 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.